Showing results (351-360 of 1,557) with videos related to

Sort By:
Pageof 156
Therapeutic Advances in Gastroenterology|June 18, 2026
Compartment-based biomarker integration for clinical monitoring in eosinophilic esophagitisAdam Wawrzeńczyk, Katarzyna Napiórkowska-Baran, Marta Tykwińska, et al.
Therapeutic Advances in Gastroenterology|July 2, 2026
Upadacitinib for anti-TNFα refractory immune checkpoint inhibitor-induced colitis: a case reportGrigorios Petrousis, Charlotte R H Hedin, Stephan L Haas, et al.
Therapeutic Advances in Gastroenterology|July 11, 2026
Using artificial intelligence to identify characteristics associated with clinical and economic outcomes in MASH (FOCUS-MASH)Kamal Kant Mangla, Semiu O Gbadamosi, Daniel Semeniuta, et al.
Therapeutic Advances in Gastroenterology|July 23, 2026
Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging rolesAxel Dignass, Catherine Reenaers, Anthony Buisson, et al.
Therapeutic Advances in Gastroenterology|July 17, 2026
Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel diseaseLydia Blacklock, Gordon Moran, Alvaro Mata, et al.
Therapeutic Advances in Gastroenterology|July 23, 2026
Noninvasive electrical neuromodulation involving vagus nerve mechanism for functional constipation and irritable bowel syndrome with constipationJie Liu, Chanlan Lv, Xiuli Zhu, et al.
Therapeutic Advances in Gastroenterology|August 6, 2026
Clinical associations, outcomes, and therapeutic management of patients with symptomatic sclerosing mesenteritisChristina Liava, Danai Chourmouzi, Georgia Gioula, et al.
Therapeutic Advances in Gastroenterology|August 2, 2026
Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLDHonglu Yu, Yuting Gao, Xiaomin Wang, et al.
Therapeutic Advances in Gastroenterology|August 5, 2026
Pulmonary diffusion abnormalities in patients with inflammatory bowel disease: A longitudinal studyHugo Maisonneuve, Benedicte Caron, Anne Guillaumot, et al.
Therapeutic Advances in Gastroenterology|August 13, 2026
Treatment persistence after switching between anti-tumor necrosis factor agents and tofacitinib in ulcerative colitis: A nationwide claims-based cohort study in South KoreaJi Eun Baek, Arum Choi, Han Hee Lee, et al.
Pageof 156